Range
29.23 - 31.06
Vol / Avg.
431.7K/459.6K
Div / Yield
-
52 Wk
15.21 - 52.38
Mkt Cap
1.4B
Payout Ratio
-
Open
30.47
P/E
-
EPS
-0.63
Shares
44.3M
Outstanding
44.3M
Total Float
31M
Benzinga - Apr 13, 2021, 4:03PM
load more
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-14
REV
Q1 2021Est.ActualSurprise
EPS-0.460-0.630 -0.1700
REV7.940M5.011M-2.929M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NRIXNurix Therapeutics0%1.4B

Nurix Therapeutics Frequently Asked Questions

Q

How do I buy Nurix Therapeutics (NRIX) stock?

A

You can purchase shares of Nurix Therapeutics (NASDAQ: NRIX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Nurix Therapeutics's (NRIX) competitors?

A

There are no as such competitors for Nurix Therapeutics.

Q

What is the target price for Nurix Therapeutics (NRIX) stock?

A

The latest price target for Nurix Therapeutics (NASDAQ: NRIX) was reported by RBC Capital on April 30, 2021. The analyst firm set a price target for 42.00 expecting NRIX to rise to within 12 months (a possible 36.45% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Nurix Therapeutics (NRIX)?

A

The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $30.78 last updated Today at 8:00:02 PM.

Q

Does Nurix Therapeutics (NRIX) pay a dividend?

A

There are no upcoming dividends for Nurix Therapeutics.

Q

When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?

A
Nurix Therapeutics’s Q2 earnings are confirmed for after-market on August 14, 2021.
Q

Is Nurix Therapeutics (NRIX) going to split?

A

There is no upcoming split for Nurix Therapeutics.

Q

What sector and industry does Nurix Therapeutics (NRIX) operate in?

A

Nurix Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.